Cefprozil is a semi-synthetic broad-spectrum cephalosporin antibiotic, and it is a second-generation cephalosporin type antibiotic. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections. It comes as a tablet and as a liquid suspension.
Due to the manufacture policy, the Cefprozil industry is relative concentrated, the manufacture technology is relative mature.
India and China are the main production areas, India with a market share of 50.79%, China with a market share of 29.03%, China Most of the products are exported to developed countries.
According to this study, over the next five years the Cefprozil market will register a 0.8% CAGR in terms of revenue, the global market size will reach US$ 140 million by 2024, from US$ 130 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cefprozil business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Cefprozil market by product type, application, key manufacturers and key regions and countries.
This study considers the Cefprozil value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Anhydrous
Monohydrate
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Pharyngitis/tonsillitis
Otitis Media
Acute Sinusitis
Secondary Bacterial Infection
Uncomplicated Skin
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Orchid
Taj Pharma
Dhanuka
Lupin
Alkem
Corden Pharma
Aurobindo
Covalent
TEVA GROUP
Hetero Drugs
Qilu Antibiotics
Dongying Pharma
Union Chempharma
Huafangpharm
Topfond
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cefprozil consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cefprozil market by identifying its various subsegments.
Focuses on the key global Cefprozil manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cefprozil with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cefprozil submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
